MARKET

DXCM

DXCM

Dexcom Inc
NASDAQ
130.69
-0.67
-0.51%
After Hours: 130.40 -0.29 -0.22% 18:45 05/20 EDT
OPEN
131.69
PREV CLOSE
131.36
HIGH
132.09
LOW
129.69
VOLUME
2.11M
TURNOVER
0
52 WEEK HIGH
142.00
52 WEEK LOW
74.75
MARKET CAP
51.97B
P/E (TTM)
86.14
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at DXCM last week (0513-0517)?
Weekly Report · 1d ago
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio Now
NASDAQ · 4d ago
Dexcom: Positive Catalysts Ahead To Support Growth
Seeking Alpha · 05/13 17:30
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Two healthcare companies have lagged the broader market over the past 12 months. Moderna and DexCom have a good chance of delivering outsized returns well beyond the current bull run. The company Moderna is a leader in the COVID-19 vaccine market. DexCom develops medical devices that allow diabetes patients to monitor their blood sugar.
The Motley Fool · 05/13 12:45
Weekly Report: what happened at DXCM last week (0506-0510)?
Weekly Report · 05/13 09:02
Baron Small Cap Fund Q1 2024 Shareholder Letter
Baron Small Cap Fund had a strong first quarter, outperforming the Russell 2000 Growth Index and the S&P 500 Index. The Fund's performance was driven by stock selection, particularly in the Industrials and Financials sectors. Shareholder letter: Baron Small Cap fund had a stellar first quarter.
Seeking Alpha · 05/10 07:35
Should iShares Russell Mid-Cap Growth ETF (IWP) Be on Your Investing Radar?
NASDAQ · 05/08 10:20
If EPS Growth Is Important To You, DexCom (NASDAQ:DXCM) Presents An Opportunity
DexCom (NASDAQ:DXCM) is a profitable company that has grown its earnings per share in the last three years. The company is growing its revenues and margins, and is a growing business. Insiders hold 0.4% of shares in the company. DexCom is on our watchlist of companies to keep an eye on.
Simply Wall St · 05/07 15:18
More
About DXCM
DexCom, Inc. is a medical device company. The Company enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The Company is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The Company is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Dexcom Stelo is designed specifically for people with type II diabetes who do not use insulin and are not at risk for hypoglycemia. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device.

Webull offers DexCom Inc stock information, including NASDAQ: DXCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DXCM stock methods without spending real money on the virtual paper trading platform.